NCT00545493 - Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Rasmussen Encephalitis

Interventions

DRUG

Tacrolimus

tacrolimus capsules, dosing according to blood trough levels: 12-15 ng/ml during months 1-6, 5-10 ng/ml during months 7-12 and 5-8 ng/ml thereafter

DRUG

i.v. immunoglobulins

infusions, dosing: initially on three consecutive days 0,4 g/kg KG, thereafter 0,4 g/kg KG every month, after 12 months of treatment every two months).

Trial Locations (1)

53115

University of Bonn, Dept. of Epileptology, Bonn